118 related articles for article (PubMed ID: 8001709)
1. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
Guillausseau PJ
Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
[TBL] [Abstract][Full Text] [Related]
2. Prevention of long-term complications of non-insulin-dependent diabetes mellitus.
Nathan DM
Clin Invest Med; 1995 Aug; 18(4):332-9. PubMed ID: 8549021
[TBL] [Abstract][Full Text] [Related]
3. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathy in diabetes mellitus: I. Causes, prevention and treatment.
Chittenden SJ; Shami SK
Diabetes Res; 1991 Jul; 17(3):105-14. PubMed ID: 1841026
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and vascular factors in the pathogenesis of diabetic neuropathy.
Ward JD
Clin Invest Med; 1995 Aug; 18(4):267-74. PubMed ID: 8549012
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
7. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
Hotta N
Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
Friedman EA
Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
[TBL] [Abstract][Full Text] [Related]
9. [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():52-61. PubMed ID: 15999685
[No Abstract] [Full Text] [Related]
10. [Microvascular complications in diabetes mellitus. Pathogenetic aspects].
Andronico G; Cerasola G
Minerva Endocrinol; 1992; 17(2):67-73. PubMed ID: 1296146
[TBL] [Abstract][Full Text] [Related]
11. Prospects for angiotensin receptor blockers in diabetic retinopathy.
Sjølie AK
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
[TBL] [Abstract][Full Text] [Related]
12. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
13. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
[TBL] [Abstract][Full Text] [Related]
14. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?
Leiter LA
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S3-14. PubMed ID: 15953505
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological approach to diabetic retinopathy.
De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
Yamagishi S; Takeuchi M
Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
[TBL] [Abstract][Full Text] [Related]
17. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
Camera A; Hopps E; Caimi G
Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
[TBL] [Abstract][Full Text] [Related]
18. Prevention of microvascular and macrovascular complications in diabetes mellitus.
Maji D
J Indian Med Assoc; 2004 Aug; 102(8):426, 428, 430 passim. PubMed ID: 15719805
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
Cameron NE; Gibson TM; Nangle MR; Cotter MA
Ann N Y Acad Sci; 2005 Jun; 1043():784-92. PubMed ID: 16037306
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase in diabetic microvascular complications.
Chung SS; Chung SK
Curr Drug Targets; 2005 Jun; 6(4):475-86. PubMed ID: 16026266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
